| Non-melanoma skin cancer V Madan, JT Lear, RM Szeimies The lancet 375 (9715), 673-685, 2010 | 1102 | 2010 |
| Basal cell carcinoma CSM Wong, RC Strange, JT Lear Bmj 327 (7418), 794-798, 2003 | 725 | 2003 |
| Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial MR Migden, A Guminski, R Gutzmer, L Dirix, KD Lewis, P Combemale, ... The Lancet Oncology 16 (6), 716-728, 2015 | 443 | 2015 |
| British Association of Dermatologists' guidelines for the management of onychomycosis 2014 M Ameen, JT Lear, V Madan, MF Mohd Mustapa, M Richardson, ... British Journal of Dermatology 171 (5), 937-958, 2014 | 345 | 2014 |
| Association between functional polymorphism in EGF gene and malignant melanoma M Shahbazi, V Pravica, N Nasreen, H Fakhoury, AA Fryer, RC Strange, ... The Lancet 359 (9304), 397-401, 2002 | 330 | 2002 |
| Heavy cigarette smoking is strongly associated with rheumatoid arthritis (RA), particularly in patients without a family history of RA D Hutchinson, L Shepstone, R Moots, JT Lear, MP Lynch Annals of the rheumatic diseases 60 (3), 223-227, 2001 | 328 | 2001 |
| Intraindividual, right–left comparison of topical methyl aminolaevulinate‐photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized … C Morton, S Campbell, G Gupta, S Keohane, J Lear, I Zaki, S Walton, ... British Journal of Dermatology 155 (5), 1029-1036, 2006 | 261 | 2006 |
| Vitamin D receptor polymorphisms are associated with altered prognosis in patients with malignant melanoma PE Hutchinson, JE Osborne, JT Lear, AG Smith, PW Bowers, PN Morris, ... Clinical Cancer Research 6 (2), 498-504, 2000 | 251 | 2000 |
| Risk factors for basal cell carcinoma in the UK: case-control study in 806 patients JT Lear, BB Tan, AG Smith, W Bowers, PW Jones, AH Heagerty, ... Journal of the Royal Society of Medicine 90 (7), 371-374, 1997 | 224 | 1997 |
| Long‐term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30‐month analysis of the randomized phase 2 BOLT study JT Lear, MR Migden, KD Lewis, ALS Chang, A Guminski, R Gutzmer, ... Journal of the European Academy of Dermatology and Venereology 32 (3), 372-381, 2018 | 197 | 2018 |
| The 12-month analysis from Basal Cell Carcinoma Outcomes with LDE225 Treatment (BOLT): a phase II, randomized, double-blind study of sonidegib in patients with advanced basal … R Dummer, A Guminski, R Gutzmer, L Dirix, KD Lewis, P Combemale, ... Journal of the American Academy of Dermatology 75 (1), 113-125. e5, 2016 | 174 | 2016 |
| Polymorphism at the Glutathione S-Transferase Locus GSTM3: Interactions with Cytochrome P450 and Glutathione S-Transferase Genotypes as Risk Factors for … L Yengi, A Inskip, J Gilford, J Alldersea, L Bailey, A Smith, JT Lear, ... Cancer research 56 (9), 1974-1977, 1996 | 169 | 1996 |
| British Association of Dermatologists’ guidelines for the safe and effective prescribing of azathioprine 2011 SJ Meggitt, AV Anstey, MF Mohd Mustapa, NJ Reynolds, S Wakelin, ... British Journal of Dermatology 165 (4), 711-734, 2011 | 153 | 2011 |
| Long‐term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42‐month analysis of the phase II randomized, double‐blind BOLT study R Dummer, A Guminksi, R Gutzmer, JT Lear, KD Lewis, ALS Chang, ... British Journal of Dermatology 182 (6), 1369-1378, 2020 | 143 | 2020 |
| Basal cell carcinoma JT Lear, AG Smith Postgraduate medical journal 73 (863), 538-542, 1997 | 136 | 1997 |
| Multiple cutaneous basal cell carcinomas: glutathione S-transferase (GSTM1, GSTT1) and cytochrome P450 (CYP2D6, CYP1A1) polymorphisms influence tumour numbers and accrual JT Lear, AHM Heagerty, A Smith, B Bowers, CR Payne, CAD Smith, ... Carcinogenesis 17 (9), 1891-1896, 1996 | 135 | 1996 |
| Melanoma in organ transplant recipients: clinicopathological features and outcome in 100 cases RN Matin, D Mesher, CM Proby, JM McGregor, JNB Bavinck, ... American Journal of Transplantation 8 (9), 1891-1900, 2008 | 126 | 2008 |
| Sonidegib and vismodegib in the treatment of patients with locally advanced basal cell carcinoma: a joint expert opinion R Dummer, PA Ascierto, N Basset‐Seguin, B Dréno, C Garbe, R Gutzmer, ... Journal of the European Academy of Dermatology and Venereology 34 (9), 1944-1956, 2020 | 123 | 2020 |
| Genetics and risk factors for basal cell carcinoma V Madan, P Hoban, RC Strange, AA Fryer, JT Lear British Journal of Dermatology 154 (s1), 5-7, 2006 | 121 | 2006 |
| Associations between ultraviolet radiation, basal cell carcinoma site and histology, host characteristics, and rate of development of further tumors TJ Lovatt, JT Lear, J Bastrilles, C Wong, CEM Griffiths, V Samarasinghe, ... Journal of the American Academy of Dermatology 52 (3), 468-473, 2005 | 121 | 2005 |
